Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
adverse drug reaction
agitation
agitation, childhood, acute
akineton
alpha methyldopa hydrazine
amantadine
aminoglycoside
amitriptyline
amphetamines
ampicillin
anesthesia, general
anterocollis
antiarrhythmic drugs
antibiotics
antibiotics, neurologic complications with
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinergic poisoning
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
artane
atropine
atropine psychosis
autonomic dysfunction
belladonna
beta adrenergic blocker
bradykinesia
brain damage
calcium antagonist
carbidopa
catatonia
catatonia, lethal
children
chloroquine
chlorpromazine
chorea
ciprofloxacin
clozapine
cogentin
coma
complications
confusion
confusional state, acute
constipation
contrast agents, neurotoxicity of
cooling therapy
creatine phosphokinase(CPK)elevated
cyproheptidine
dehydration
delirium
dementia
deprenyl
dilantin
dopamine
dopamine agonist
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug overdose
drug withdrawal
dyskinesia
dystonia
dystonia, cervical
dystonia, drug induced
dystonia, face
dystonia, focal
dystonia, treatment of
dystonia, truncal
dystonic reaction, acute
emergencies, medical
emergencies, neurologic
enzyme inhibition
erythromycin
exercise
fever
fluoroquinolones
grasping
hallucination
hallucination, visual
haloperidol
heatstroke
herbs
hyperthermia
iatrogenic neurologic disorders
imipramine
interferon
L-dopa
L-dopa, controlled release
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
leukocytosis
levonorgestrel
lithium
livedo reticularis
liver function enzymes
malignant hyperpyrexia
memory, defect of recent
memory, impairment of
mental status, abnormal
methacholine
migraine
migraine, prophylaxis
misdiagnosis
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, treatment of
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, unmasked
myasthenic syndrome
myoglobinuria
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuromuscular blockade
nicotine
obesity
old age, neurology of
orthostatic hypotension
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, fluctuations in
Parkinson disease, misdiagnosis
Parkinson disease, on-off phenomena in
Parkinson disease, treatment of
parsidol
patient information and support
penicillamine
personality change
phenothiazine
physostigmine
Pisa syndrome
poison, neurologic problems with
prevention of neurologic disorders
procyclidine
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychosis, acute
pupil, abnormality in neurologic disorders
pupil, dilated, bilateral
pyridoxine
quinidine
renal failure
reserpine and reserpine like drugs
retrocollis
review article
rhabdomyolysis
rigidity
risk factors
ritalin
schizophrenia
seizure
serotonin syndrome
sinemet
skin, dry
steroid
tachycardia
tardive dystonia
tea
timolol
toxins, nervous system
tranquilizers, neurologic complications with
treatment of neurologic disorder
tremor
tricyclic antidepressant
verapamil
vertigo
vertigo, treatment of
vision, blurred
vitamin, multiple
xerostomia
Showing articles 1800 to 1850 of 8417 << Previous Next >>

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004

Cardiac Arrhythmias in Focal Epilepsy: A Prospective Long-Term Study
Lancet 364:2212-2219,2157, Rugg,F.J.,et al, 2004

Statin-Associated Exacerbation of Myasthenia Gravis
Neurol 63:2188, Cartwright,M.S.,et al, 2004

Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 35:2610-2611, Horrocks,J.A.,et al, 2004

Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004

Clomipramine Induced Neuroleptic Malignant Syndrome and Pyrexia of Unknown Origin
BMJ 329:1333-1335, Haddow,A.M.,et al, 2004

Sibutramine May Be Associated With Memory Impairment
BMJ 329:1316, Clark,D.W.J. &Harrison-Woolrych,M., 2004

Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004

The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004

Guillain-Barre Syndrome Follwoing Influenza Vaccination
JAMA 292:2478-2481, Haber,P.,et al, 2004

Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Anticoagulation Rather Than Stockings Alone: Against
Stroke 35:2912-2913,2910, Dennis,M.S., 2004

Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Angicoagulation Rather Than Stockings Alone: For
Stroke 35:2911-2912,2910, Adams,H.P., 2004

Incidence of Hospitalized Rhabdomyloysis in Patients Treated With Lipid-Lowering Drugs
JAMA 292:2585-2590, Graham,D.J.,et al, 2004

Suicide After Successful Deep Brain Stimulation for Movement Disorders
Neurol 63:2170-2172, Burkhard,P.R.,et al, 2004

Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004

Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004

Surgical and Hardware Complications of Subthalamic Stimulation
Neurol 63:612-616, Lyons,K.E.,et al, 2004

Hallucinations During Methylphenidate Therapy
Neurol 63:753-754, Gross-Tsur,V.,et al, 2004

Acquired Haemophilia A May be Associated with Clopidogrel
BMJ 329:323, Haj,M.,et al, 2004

Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004

Rapid Infusion with Valproate Sodium is Well Tolerated in Patients with Epilepsy
Neurol 63:1507-1508, Wheless,J.W.,et al, 2004

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

A Controlled Study of Peripheral Neuropathy After Bariatric Surgery
Neurol 63:1462-1470, Thaisetthawatkul,P.,et al, 2004

Oral Antispastic Drugs in Nonprogressive Neurologic Diseases
Neurol 63:1357-1363, Montane,E.,et al, 2004

Risk of Ischemic Stroke with Tamoxifen Treatment for Breast Cancer
Neurol 63:1230-1233, Bushnell,C.D. &Goldstein,L.B., 2004

Effect of Intravenous Corticosteroids on Death Within 14 Days in 10008 Adults with Clinically Significant Head Injury (MRC CRASH Trial): Randomised Placebo-Controlled Trial
Lancet 364:1321-1328,1291, CRASH Trial Collaborators, 2004

Narcolepsy and Excessive Daytime Sleepiness
BMJ 329:724-728, Zeman,A.,et al, 2004

Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004

Warfarin, Hematoma Expansion, and Outcome of Intracerebral Hemorrhage
Neurol 63:1059-1064, Flibotte,J.J.,et al, 2004

Tacrolimus Leukoencephalopathy: A Neuropathologic Confirmation
Neurol 63:1132-1133, Lavigne,C.M.,et al, 2004

The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004

Should the MATCH Results be Extrapolated to All Stroke Patients and Affect Ongoing Trials Evaluating Clopidogrel Plus Aspiring?
Stroke 35:2606-2608, Amarenco,P. &Donna,G. A., 2004

Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004

Post-Stroke Movement Disorders; Report of 56 Patients
JNNP 75:1568-1574, Alarcon,F.,et al, 2004

Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004

Systematic Screening Allows Reduction of Adverse Antiepileptic Drug Effects
Neurol 62:23-27, Gilliam,F.G.,et al, 2004

Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004

Clopidogrel-Associated TTP, An Update of Pharmacovigilance Efforts
Stroke 35:533-538, Zakarija,A.,et al, 2004

Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004

Tamoxifen:A New Risk Factor for Cerebral Sinus Thrombosis
Neurol 62:334-335, Masjuanh,J.,et al, 2004

Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
NEJM 350:896-903,860, Mutsch,M.,et al, 2004

Trpitans in Migraine
Neurol 62:563-568, Hall,G.C.,et al, 2004

Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004

Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004



Showing articles 1800 to 1850 of 8417 << Previous Next >>